Cancer Diagnostics Market Report

Global and Region Cancer Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：153
  • REPORT CODE：GMM1010502
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

    North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.

    The report details the trend, potential and market size of Cancer Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Diagnosticsmarket, defines the market attractiveness level of Cancer Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Diagnostics industry, describes the types of Cancer Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Diagnostics market and the development prospects and opportunities of Cancer Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Diagnostics market in Chapter 13.

    By Player:

    • Becton, Dickinson and Company

    • Abbott

    • CR Bard

    • GE Healthcare

    • Agilent Technologies

    • Roche

    • Illumina

    • Siemens Healthcare

    • Thermo Fisher Scientific

    By Type:

    • Platform-based

    • Instrument-based

    By End-User:

    • Breast Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Melanoma

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Diagnostics Consumption (2017-2022)

    • 7.2 United States Cancer Diagnostics Consumption (2017-2022)

    • 7.3 Europe Cancer Diagnostics Consumption (2017-2022)

    • 7.4 China Cancer Diagnostics Consumption (2017-2022)

    • 7.5 Japan Cancer Diagnostics Consumption (2017-2022)

    • 7.6 India Cancer Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Cancer Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Cancer Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Diagnostics Consumption Forecast (2022-2028)

    9 Global Cancer Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Platform-based Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Instrument-based Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Melanoma Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cancer Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Platform-based Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Instrument-based Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Diagnostics Market Competitive Analysis

    • 14.1 Becton, Dickinson and Company

      • 14.1.1 Becton, Dickinson and Company Company Details

      • 14.1.2 Becton, Dickinson and Company Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Becton, Dickinson and Company Cancer Diagnostics Product and Service

    • 14.2 Abbott

      • 14.2.1 Abbott Company Details

      • 14.2.2 Abbott Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abbott Cancer Diagnostics Product and Service

    • 14.3 CR Bard

      • 14.3.1 CR Bard Company Details

      • 14.3.2 CR Bard Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CR Bard Cancer Diagnostics Product and Service

    • 14.4 GE Healthcare

      • 14.4.1 GE Healthcare Company Details

      • 14.4.2 GE Healthcare Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GE Healthcare Cancer Diagnostics Product and Service

    • 14.5 Agilent Technologies

      • 14.5.1 Agilent Technologies Company Details

      • 14.5.2 Agilent Technologies Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Agilent Technologies Cancer Diagnostics Product and Service

    • 14.6 Roche

      • 14.6.1 Roche Company Details

      • 14.6.2 Roche Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Roche Cancer Diagnostics Product and Service

    • 14.7 Illumina

      • 14.7.1 Illumina Company Details

      • 14.7.2 Illumina Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Illumina Cancer Diagnostics Product and Service

    • 14.8 Siemens Healthcare

      • 14.8.1 Siemens Healthcare Company Details

      • 14.8.2 Siemens Healthcare Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Siemens Healthcare Cancer Diagnostics Product and Service

    • 14.9 Thermo Fisher Scientific

      • 14.9.1 Thermo Fisher Scientific Company Details

      • 14.9.2 Thermo Fisher Scientific Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Thermo Fisher Scientific Cancer Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Diagnostics

    • Figure Cancer Diagnostics Picture

    • Table Global Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Diagnostics Consumption by Country (2017-2022)

    • Figure United States Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Platform-based Consumption and Growth Rate (2017-2022)

    • Figure Global Instrument-based Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Melanoma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Platform-based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Instrument-based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)

    • Table Becton, Dickinson and Company Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton, Dickinson and Company Cancer Diagnostics Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Cancer Diagnostics Product and Service

    • Table CR Bard (Foundation Year, Company Profile and etc.)

    • Table CR Bard Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table CR Bard Cancer Diagnostics Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Cancer Diagnostics Product and Service

    • Table Agilent Technologies (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Cancer Diagnostics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Cancer Diagnostics Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Cancer Diagnostics Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Cancer Diagnostics Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Cancer Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US